HomeCompareEVGGF vs MRK

EVGGF vs MRK: Dividend Comparison 2026

EVGGF yields 5.09% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EVGGF wins by $6819.27M in total portfolio value
10 years
EVGGF
EVGGF
● Live price
5.09%
Share price
$61.45
Annual div
$3.13
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6819.33M
Annual income
$6,571,408,783.26
Full EVGGF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — EVGGF vs MRK

📍 EVGGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEVGGFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EVGGF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EVGGF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EVGGF
Annual income on $10K today (after 15% tax)
$432.82/yr
After 10yr DRIP, annual income (after tax)
$5,585,697,465.77/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, EVGGF beats the other by $5,585,689,137.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EVGGF + MRK for your $10,000?

EVGGF: 50%MRK: 50%
100% MRK50/50100% EVGGF
Portfolio after 10yr
$3409.69M
Annual income
$3,285,709,290.70/yr
Blended yield
96.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EVGGF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
6.1
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EVGGF buys
0
MRK buys
0
No recent congressional trades found for EVGGF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEVGGFMRK
Forward yield5.09%2.76%
Annual dividend / share$3.13$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$6819.33M$56.8K
Annual income after 10y$6,571,408,783.26$9,798.13
Total dividends collected$6801.96M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: EVGGF vs MRK ($10,000, DRIP)

YearEVGGF PortfolioEVGGF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,718$1,018.40$11,206$366.19+$512.00EVGGF
2$14,769$2,230.66$12,650$502.35+$2.1KEVGGF
3$21,058$5,255.01$14,407$694.19+$6.7KEVGGF
4$36,537$14,004.88$16,585$967.82+$20.0KEVGGF
5$84,514$45,419.16$19,342$1,363.89+$65.2KEVGGF
6$286,802$196,371.64$22,913$1,947.19+$263.9KEVGGF
7$1,552,476$1,245,598.67$27,662$2,823.89+$1.52MEVGGF
8$14,263,973$12,602,823.08$34,159$4,173.35+$14.23MEVGGF
9$231,698,486$216,436,035.44$43,337$6,308.80+$231.66MEVGGF
10$6,819,326,164$6,571,408,783.26$56,776$9,798.13+$6819.27MEVGGF

EVGGF vs MRK: Complete Analysis 2026

EVGGFStock

Evolution AB (publ) develops, produces, markets, and licenses live casino and slots solutions to gaming operators primarily in Europe and the United States. The company runs the game from a casino gaming table, which is streamed in real time and end users make betting decisions on their devices, such as computers, smartphones, tablets, etc. Its portfolio of online live table games primarily includes Live Roulette, Blackjack, Baccarat, Super Sic Bo, Dragon Tiger, Craps, Live Casino Hold'em, Three Card Poker, and Ultimate Texas Hold'em; and operates approximately 1000 tables. The company was formerly known as Evolution Gaming Group AB (publ). Evolution AB (publ) was founded in 2006 and is headquartered in Stockholm, Sweden.

Full EVGGF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this EVGGF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EVGGF vs SCHDEVGGF vs JEPIEVGGF vs OEVGGF vs KOEVGGF vs MAINEVGGF vs JNJEVGGF vs ABBVEVGGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.